Methodology
The enrolled sample population were randomized into experimental and control groups using computer generated block of four with allocation concealment. Sucralfate was then distributed only to the randomized experimental group on postoperative day0. All patients were instructed and assigned the same analgesic protocol. Study participants were then scheduled for wound assessment and VAS score collection at day7 and day14.
Initially, 43 enrolled patients were assessed for eligibility, 10 patients were excluded due to enrollment criteria and 3 patients declined voluntarily participation, resulting in final enrollment of 30 patients included in the study and randomized into. Control group (n=16) and Sucralfate group (n=14). In the control group, 3 patients were lost to contact, 4 patients were lost to wound assessment follow up at day7 and 3 patients were lost to wound assessment follow up at day14. In the Sucralfate group, 1 patient was lost to contact, 5 patients were lost to wound assessment follow up at day7, and 1 patient lost to wound assessment follow up at day14. Collected data was then analysed and reported in reference to CONSORT guideline.